RAFAEL HOLDINGS, INC. Gain (Loss) on Fair Value Hedges Recognized in Earnings
RAFAEL HOLDINGS, INC. (RFL) reported Gain (Loss) on Fair Value Hedges Recognized in Earnings of $0 for the 12-month period ending 2023-07-31, per its 10-K filed 2023-10-30.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings · last filed 2023-10-30
- RAFAEL HOLDINGS, INC. gain (loss) on fair value hedges recognized in earnings for the quarter ending 2023-07-31 was $0.00.
- RAFAEL HOLDINGS, INC. gain (loss) on fair value hedges recognized in earnings for the quarter ending 2022-07-31 was $0.00.
- RAFAEL HOLDINGS, INC. gain (loss) on fair value hedges recognized in earnings for the quarter ending 2022-04-30 was $0.00.
- RAFAEL HOLDINGS, INC. gain (loss) on fair value hedges recognized in earnings for the quarter ending 2022-01-31 was $0.00.
- RAFAEL HOLDINGS, INC. gain (loss) on fair value hedges recognized in earnings for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- RAFAEL HOLDINGS, INC. gain (loss) on fair value hedges recognized in earnings for fiscal 2022 was $575.00K, a 50.13% increase from fiscal 2021.
- RAFAEL HOLDINGS, INC. gain (loss) on fair value hedges recognized in earnings for fiscal 2021 was $383.00K.
| Period end | Gain (Loss) on Fair Value Hedges Recognized in Earnings 3 month | Gain (Loss) on Fair Value Hedges Recognized in Earnings 6 month | Gain (Loss) on Fair Value Hedges Recognized in Earnings 9 month | Gain (Loss) on Fair Value Hedges Recognized in Earnings 12 month |
|---|---|---|---|---|
| 2023-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-30 | $0.00 10-K · filed 2023-10-30 | ||
| 2023-04-30 | $0.00 10-Q · filed 2023-06-13 | |||
| 2022-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-30 | $0.00 derived: sum of 2 quarters · filed 2023-10-30 | $0.00 derived: sum of 3 quarters · filed 2023-10-30 | $575.00K 10-K · filed 2023-10-30 |
| 2022-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-06-13 | $0.00 derived: sum of 2 quarters · filed 2023-06-13 | $575.00K 10-Q · filed 2023-06-13 | |
| 2022-01-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-03-14 | $575.00K 10-Q · filed 2023-03-14 | ||
| 2021-10-31 | $575.00K 10-Q · filed 2022-12-13 | |||
| 2021-07-31 | $383.00K 10-K · filed 2022-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |